(Q43036903)

12 November 2017

title

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis (English)

1 reference

12 November 2017

1 reference

1 reference

5

1 reference

12 November 2017

Manuela G Neuman

1

1 reference

12 November 2017

J P Benhamou

2

1 reference

12 November 2017

I M Malkiewicz

3

1 reference

12 November 2017

A Ibrahim

4

1 reference

12 November 2017

M Martinot-Peignoux

6

1 reference

12 November 2017

T Asselah

7

1 reference

12 November 2017

M Bourliere

8

1 reference

12 November 2017

G G Katz

9

1 reference

12 November 2017

N H Shear

10

1 reference

12 November 2017

P Marcellin

11

1 reference

12 November 2017

publication date

1 March 2002

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

9

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

134-140

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Hepatitis C virus genotypes and risk of cirrhosis in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Natural history of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

Sexual transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00343.X

10.1046/J.1365-2893.2002.00343.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference